Effect of exercise-induced activation of sympathetic nerve activity on clearance of 123I-MIBG from the myocardium

Annals of Nuclear Medicine

Volumn 12, Issue 4, 1998, Pages 175-178

  Sugihara, Hiroki ^a   Shiga, Koji ^a   Terada, Kouji ^a   Kinoshita, Noriyuki ^a   Taniguchi, Yoko ^a   Ito, Kazuki ^a   Adachi, Yoshihiko ^a   Ushijima, Yo ^a   Nakagawa, Masao ^a   Maeda, Tomoho ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

123I MIBG scintigraphy; Cardiac sympathetic nerve function; Clearance rate; Exercise

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG CLEARANCE; EXERCISE; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC NERVE;

EID: 0031685029     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164841     Document Type: Article

References (21)

1. Kline RC, Swanson DP, Wieland DM, Myocardial imaging in man with I-123 metaiodobenzylguanidine. J Nucl Med 22: 129-132, 1981.
2. 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Comm 15: 317-323, 1994.
3. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78: 1192-1199, 1988.
4. Morimoto S, Terada K, Keira N, Satoda M, Inoue K, Tatsukawa H, et al. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine. Eur J Nucl Med 23: 756-761, 1996.
5. Merlet P, Valette H, Dubous-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33: 471-477, 1992.
6. 123I-BMIPP imaging. Ann Nucl Med 8: 177-182, 1994.
7. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 36: 969-974, 1995.
8. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibitor reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38: 1085-1089, 1997.
9. Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 133: 353-358, 1997.
10. Taniguchi Y, Sugihara H, Terada K, Ito K, Ohtsuki K, Shiga K, et al. Myocardial ischemia and abnormality of cardiac sympathetic nervous function in apical hypertrophic cardiomyopathy. J Cardiol 24: 293-298, 1994.
11. Nakajima K, Bunko H, Taki J, Shimizu M, Muramori A, Hisada K. Quantitative analysis of I-123 metaiodobenzylguanidine (MIBG) uptake in hypertrophie cardiomyopathy. Am Heart J 119: 1329-1337, 1990.
12. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. J Nucl Med 37: 712-717, 1996.
13. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 26: 1594-1599, 1995.
14. 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease. J Cardiol 25: 247-253, 1995.
15. Dae MW, O'Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 79: 634-644, 1989.
16. Brush JE, Eisenhofer G, Garty M, Stull R, Maron BJ, Cannon RO, et al. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 79: 836-844, 1989.
17. Tobes MC, Jaques S, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 26: 897-907, 1985.
18. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tonoue P, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 27: 84-89, 1986.
19. Dae MW, Marco TD, Botvinik EH, O'Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - Implications for clinical studies. J Nucl Med 33: 1444-1450, 1992.
20. Saito M, Mano T, Iwase S. Changes in muscle sympathetic nerve activity and calf blood flow during static exercise. Eur J Appl Physiol 60: 277-281, 1990.
21. Nakajo M, Shapiro B, Sisson JC, Beirwaltes WH. Inverse relationship between cardiac accumulation of metaiodobenzylguanidine and circulationg catecholamines in suspected pheochromocytoma. J Nucl Med 24: 1127-1134, 1983.